Patient Safety at Risk: Former FDA Official Warns of Dangers from Compounded GLP-1s
WASHINGTON, DC, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- As the demand for GLP-1 medications skyrockets, patients are increasingly targeted with compounded knockoffs that are not FDA approved and do not meet federal safety or quality …